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ABSTRACT We used ﬂuorescence correlation spectroscopy (FCS) to analyze the binding of ﬂuorescently labeled peptides to
lipid vesicles and compared the deduced binding constants to those obtained using other techniques. We used a well-
characterized peptide corresponding to the basic effector domain of myristoylated alanine-rich C kinase substrate,
MARCKS(151–175), that was ﬂuorescently labeled with Alexa488, and measured its binding to large unilamellar vesicles
(diameter ;100 nm) composed of phosphatidylcholine and phosphatidylserine or phosphatidylinositol 4,5-bisphosphate.
Because the large unilamellar vesicles are signiﬁcantly larger than the peptide, the correlation times for the free and bound
peptide could be distinguished using single color autocorrelation measurements. The molar partition coefﬁcients calculated
from the FCS measurements were comparable to those obtained from binding measurements of radioactively labeled
MARCKS(151–175) using a centrifugation technique. Moreover, FCS can measure binding of peptides present at very low
concentrations (1–10 nmolar), which is difﬁcult or impossible with most other techniques. Our data indicate FCS can be an
accurate and valuable tool for studying the interaction of peptides and proteins with lipid membranes.
INTRODUCTION
The binding of peripheral proteins to membranes is crucial
for biological processes such as signal transduction and
vesicle trafﬁcking (DiNitto et al., 2003). Translocation of
proteins from the cytoplasm to the plasma membrane
increases their local concentration in the membrane phase
;1000-fold, as discussed in detail elsewhere (Adam and
Delbru¨ck, 1968; Berg and Purcell, 1977; Kholodenko et al.,
2000; McCloskey and Poo, 1986; McLaughlin and Aderem,
1995) . For example, the C1 and C2 domains of protein
kinase C (PKC) mediate its translocation to the plasma
membrane, where it is exposed to a signiﬁcantly higher
effective concentration of its membrane-bound substrates
(Cullen, 2003; Mellor and Parker, 1998; Newton, 2003). The
myristoylated alanine-rich C kinase substrate (MARCKS)
protein, the main substrate of PKC in many cell types
(Anderem, 1992; Arbuzova et al., 2002; Blackshear, 1993),
is anchored to the membrane by an N-terminal myristate and
a cluster of basic residues in its effector domain (McLaughlin
and Aderem, 1995). PKC phosphorylation of three serines in
the MARCKS effector domain weakens its electrostatic
attraction to acidic lipids in the plasma membrane, resulting
in translocation of MARCKS to the cytoplasm in living cells
(Ohmori et al., 2000).
Several different laboratories have investigated the mem-
brane binding of the proteins in the calcium/phospholipid
secondmessenger system (i.e., G-proteins, phosphoinositide-
speciﬁc phospholipase C, PKC,MARCKS) using a variety of
techniques. A recent monograph on peptide-lipid interactions
discusses biophysical techniques such as isothermal titration
calorimetry (ITC), ﬂuorescence resonance energy transfer,
spin labeling, and centrifugation (Simon and McIntosh,
2002). Fluorescence correlation spectroscopy (FCS) is an
alternative technique that has deﬁnite advantages for studying
protein-membrane (and protein-protein) interactions (Elson
and Magde, 1974; Magde et al., 1972, 1974). FCS measures
ﬂuctuations in the emission spectra of a small number of
ﬂuorescent molecules diffusing into and out of the focus
volume of an excitation laser. Statistical analysis of these
ﬂuctuations yields correlation curves carrying information
about diffusion, chemical reactions, and other processes
(Elson, 2001). Although FCS was developed 30 years ago,
recent technical advances have led to a renaissance of interest
in this technique; several recent brief reviews (Hess et al.,
2002; Krichevsky and Bonnet, 2002; Muller et al., 2003;
Schwille and Haustein, 2002; Thompson et al., 2002; Van
Craenenbroeck and Engelborghs, 2000) and a monograph
(Rigler and Elson, 2001) describe these developments and
their application to a variety of model and cellular systems.
Before using FCS for detailed studies of protein-membrane
interactions, however, we need to demonstrate that the
technique provides accurate measurements. Hence these
studies focus on the binding of simple, well-characterized
peptides to phospholipid vesicles, which allows us to compare
the measurements to values determined by conventional,
well-established techniques. Large unilamellar vesicles
(LUVs) formed by extrusion through 100 nm diameter pores
are particularly well-suited for these experiments because
they are both thermodynamically stable (in contrast to
sonicated vesicles) and uniform in size (in contrast to both
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ethanol-injected vesicles and multilamellar vesicles); these
100 nm vesicles have been characterized by a number of
techniques (Hope et al., 1985). Moreover, LUVs are
signiﬁcantly larger than typical proteins and peptides,
permitting separation of two correlation times in single-
color autocorrelation measurements. Although FCS has been
used previously to measure the binding of proteins to vesicles
(Dorn et al., 1998; Takakuwa et al., 1999), no detailed
comparisons of results obtained with FCS results and those
from more conventional techniques have appeared in the
literature. We chose to work with a peptide that corresponds
to the effector domain of the MARCKS protein,
MARCKS(151–175). This 25-mer peptide has 13 basic and
ﬁve aromatic residues. The membrane binding of both
MARCKS and the effector domain peptide has been studied
by several different techniques, as reviewed elsewhere
(Arbuzova et al., 2002; McLaughlin and Aderem, 1995;
McLaughlin et al., 2002; Qin and Caﬁso, 1996). The peptide
binds only weakly to electrically neutral vesicles (e.g., those
formed from phosphatidylcholine, PC) through its ﬁve
aromatic residues; the binding increases exponentially with
increasing mole fraction of acidic lipid (e.g., phosphatidyl-
serine, PS), as expected for electrostatic interactions
(Arbuzova et al., 2000). This allows us to measure the
binding of a single peptide to LUVs over the entire range
accessible with FCS measurements (effective dissociation
constant of peptide with lipid is;1 mM to 10 nM) by simply
changing the fraction of acidic lipid in the vesicles.
The binding of MARCKS and its effector domain to
phospholipid vesicles is also of biological interest. Although
MARCKS is present at high concentrations in cells, its
physiological role is unknown. One hypothesis is that
MARCKS reversibly sequesters phosphatidylinositol 4,5-
bisphosphate (PIP2) through its effector domain, then
releases PIP2 upon PKC phosphorylation or binding of
calcium/calmodulin (Ca/CaM) (Gambhir et al., 2004). There
is also much interest in using single molecule techniques to
study the interaction of Ca/CaM with biological effectors.
Thus, our FCS studies of MARCKS peptide binding to PC/
PIP2 vesicles provide the basis for single molecule studies of
calmodulin. Finally, several recent theoretical articles de-
scribing the binding of basic peptides to membranes consider
the possible redistribution of monovalent acidic lipids when
a basic peptide binds to the membrane (Haleva et al., 2004;
May et al., 2000) whereas other reports assume the
redistribution is negligible (Wang et al., 2004). Thus, an
accurate description of how the partitioning depends on the
mole fraction of acidic lipid in the membrane is useful for
testing different theoretical approaches.
We demonstrate that FCS can accurately determine the
binding constants of ﬂuorescently labeled peptides to
vesicles. We labeled a peptide corresponding to the effector
domain of MARCKS, MARCKS(151–175) with Alexa488,
then measured its binding to PC/PS vesicles using FCS. We
compared the FCS results to those available from other
measurements (e.g., centrifugation experiments with radio-
actively labeled MARCKS(151–175)) and observed excel-
lent agreement over the entire ﬁve orders of magnitude range
of the partition coefﬁcient. This suggests that FCS can be
used with conﬁdence to study the membrane binding of more
complicated proteins to LUVs. We conclude with a
discussion of the advantages of the FCS approach over
more conventional techniques (e.g., centrifugation, equilib-
rium dialysis, ITC).
EXPERIMENTAL SETUP
Fig. 1 illustrates the principle of FCS and the binding
mechanism of ﬂuorescently labeled MARCKS(151–175) to
negatively charged lipid membranes. Fig. 1 A is a sketch of
a free and vesicle-bound peptide undergoing Brownian
motion in the laser focus volume. We used the one-color
autocorrelation method to measure the diffusion of the
labeled peptide into and out of the illuminated volume. A
photodiode detects the ﬂuctuation in ﬂuorescence, which is
analyzed by a digital correlator. These measurements are
expressed as a correlation time for the free peptide, i.e., the
time it takes for the peptide to diffuse in and out of the;300
nm diameter detection region. We then add unlabeled large
unilamellar vesicles, LUVs (monodisperse 100 nm diameter
phospholipid vesicles), and monitor the autocorrelation
function as the vesicle concentration increases and ﬂuores-
cent peptides bind to the vesicles. Because the bound
peptides diffuse more slowly, they have a signiﬁcantly
higher (;25-fold) correlation time (tbound tfree); hence the
free and bound species can be distinguished easily. Fig. 1 B
shows an idealized autocorrelation function.
The apparent dissociation constant, Kd, of the peptide with
lipid is, by deﬁnition, the lipid concentration at which 50%
of the peptide is bound. Describing the interaction with a Kd
would be appropriate if the peptide formed a 1:1 complex
with a lipid. However, the peptide actually partitions onto the
vesicle because of nonspeciﬁc electrostatic and hydrophobic
interactions (Arbuzova et al., 2000). Thus we describe the
binding with a molar partition coefﬁcient deﬁned as K ¼
1/Kd (see Eq. 4 below). Fig. 1 C shows the basic effector
domain of MARCKS(151–175) binding to a negatively
charged PC/PS lipid membrane: the 25-residue peptide is in
an extended (;7 nm) conformation both in solution and
bound to PC/PS and PC/PIP2 membranes (see Fig. 1 in
Gambhir et al., 2004 and references therein). The 13 basic
residues (indicated with plus signs) interact electrostatically
with the acidic lipids in the membrane. The ﬁve aromatic
phenylalanine residues, which insert to the level of the acyl
chain region of the lipids, are not illustrated (Ellena et al.,
2003; Zhang et al., 2003). The relatively weak binding of the
peptide to electrically neutral bilayers illustrates that these
hydrophobic interactions provide only a minor contribution
to the strong binding observed with the peptide to negatively
charged vesicles (Arbuzova et al., 2000).
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We used the hydrophilic ﬂuorophore Alexa488, which
was covalently bound via a Cys at the N-terminus of the
peptide; ESR measurements show that the highly basic
amino terminal region of the MARCKS(151–175) peptide
does not penetrate the polar headgroup region of the bilayer
(Qin and Caﬁso, 1996). Thus, attaching a hydrophilic
ﬂuorophore to this region of the peptide should not
signiﬁcantly affect the molar partition coefﬁcient of the
peptide. In contrast, hydrophobic ﬂuorescent probes partition
into the membrane and enhance the value of K (e.g., at-
taching TexasRed to most small basic peptides increases K
;100-fold for negatively charged vesicles). In brief,
Alexa488 is an excellent ﬂuorophore for FCS measurements:
it has low triplet state excitation, a high quantum yield, and
high photostability (Schwille and Haustein, 2002).
FCS measurements were performed with an Axiovert 200
microscope with a ConfoCor2 unit equipped with an
403/1.2 water immersion objective (Apochromat) and a
continuous argon ion laser (Zeiss, Jena, Germany). The
excitation of the ﬂuorophore was at 488 nm with an incident
laser power of 120 mW for all experiments. The ConfoCor2
software controlled the experimental setup and produced the
autocorrelation data. The samples were measured in LabTek
II chamber slides with eight wells (Nunc, Wiesbaden,
Germany). We minimized the adsorption of the peptide to
the chamber during the experiment by precoating the
chambers with a neutral lipid bilayer. Brieﬂy, we added
a low concentration of sonicated unilamellar vesicles formed
from PC to the chambers and incubated them overnight.
Before use, we rinsed the chambers gently ﬁve times with
buffer to remove free sonicated unilamellar vesicles. The
laser focus was positioned in solution ;200 mm above the
top surface of the cover slide. The focus volume was
determined by calibration with a 30 nM Rhodamine 6G
solution (diffusion constant DRh6G ¼ 2.8 3 1010 m2 s1;
Magde et al., 1974).
MATERIALS
We used Rhodamine 6G in buffer solution containing 100
mM NaCl, 10 mM HEPES, pH 7 (Merck, Darmstadt,
Germany) for system calibration. PC (1-palmitoyl-2-oleoyl-
sn-glycero-3-phosphatidylcholine) and PS (1-palmitoyl-2-
oleoyl-sn-glycero-3-phosphatidylserine) were obtained from
Avanti Polar Lipids (Alabaster, AL). The ammonium salt of
L-a-phosphatidylinositol 4,5-bisphosphate (PIP2) was pur-
chased from Boehringer (Mannheim, Germany). LUVs were
FIGURE 1 Determination of binding afﬁnities of peptides for large
unilamellar vesicles (LUVs) with FCS. (A) Sketch of the detection volume of
the FCS instrument. A free ﬂuorescent peptide and a 100 nm diameter LUV,
shown with an adsorbed peptide, diffuse in and out of the volume, producing
ﬂuctuations in the ﬂuorescence intensity. A free ﬂuorescent peptide has
a correlation time tfree ;0.1 ms, and the peptide bound to the vesicle has
a longer correlation time, tbound ;2 ms, because its diffusion coefﬁcient is
lower. If the peptide concentration is 10 nM, the ;0.3 ﬂ detection volume
contains approximately one free peptide. The detection volume (diameter
;300 nm), LUV (diameter ;100 nm), and peptide (length ;7 nm) are
drawn approximately to scale. (B) Plot of an idealized two-component
autocorrelation function for tfree  tbound. The correlation times are
indicated with dashed vertical lines. When the fractions of free and bound
peptide are identical, the molar partition coefﬁcient, K ¼ 1/[lipid]. Modiﬁed
from Van Craenenbroeck and Engelborghs (2000). (C) Sketch of a peptide
corresponding to the basic effector domain of MARCKS, MARCKS(151–
175), bound to a negatively charged PC/PS lipid membrane. The peptide has
13 basic residues (indicated by 1; the sequence is acetyl-
CKKKKKRFSFKKSFKLSGFSFKKNKK-amide); the ﬂuorescent probe
Alexa488 is attached covalently to the Cys residue at the N-terminus. As
described in the text, several different measurements indicate the peptide is
in an extended conformation with the ﬁve Phe residues penetrating to the
level of the acyl side chains. Most of the binding energy comes from
nonspeciﬁc electrostatic interactions between the basic residues and the
acidic lipids in the LUV.
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prepared by drying the lipid mixture on a rotary evaporator,
hydrating the lipids in a solution containing 100 mMKCl, 10
mM HEPES, pH 7, then taking the multilamellar vesicles
through ﬁve cycles of freezing and thawing followed by 10
extrusion cycles through a stack of two polycarbonate ﬁlters
(100 nm pore size diameter) using the mini-extruder from
Avanti Polar Lipids (Hope et al., 1985). As discussed in
detail elsewhere (Wang et al., 2002), several steps in the
preparation of PIP2 containing vesicles require special
attention: 1), PIP2 is less soluble in chloroform than most
lipids and the formation of mixed lipid ﬁlms requires rapid
evaporation; 2), PIP2 is less stable than conventional lipids;
and 3), PIP2 can be lost more readily than most lipids during
the extrusion procedure. Thus, we regard the comparison
with data in the literature obtained with PC/PS vesicles as the
best test of the utility of the FCS technique.
The peptide corresponding to the basic effector domain of
bovine MARCKS (residues 151–175) was obtained from
the Proteomics Center, State University of New York
(Stony Brook, NY). The amino acid sequence of the effector
domain is
KKKKKRFSFKKSFKLSGFSFKKNKK:
The peptide was synthesized with an extra Cys residue at
the N-terminus to facilitate labeling with Alexa488 (Molec-
ular Probes, Eugene, OR). The ends were blocked with
acetyl and amide groups, producing a peptide with 13
positive and zero negative charges. Alexa488, however, has
one positive and three negative charges at pH 7; in principle,
these charges could affect the electrostatic binding of the
peptide to the vesicles. The probe was attached to the region
of peptide that is most distal to the membrane when the
peptide binds (Fig. 1 C), assuming that it would not affect the
value of the partition coefﬁcient, K, signiﬁcantly. Indepen-
dent centrifugation measurements conﬁrm that Alexa-
labeled and radioactively NEM-labeled MARCKS(151–
175) bind with similar values of K to PC/PS (10:1) vesicles
(data not shown). The purity of the ﬁnal labeled peptide was
checked with mass spectroscopy and HPLC; we estimate the
labeled peptide was .95% pure. All buffer solutions were
prepared with deionized water (conductivity ,0.1 106
S/m). Solutions were degassed before use to minimize air
bubble formation during the measurements.
DATA ANALYSIS
The signal I(t) generated by ﬂuorescent molecules diffusing
through the detection volume ﬂuctuates around a mean value
I(t) ¼ ÆI(t)æ1dI(t). The normalized time correlation function
is deﬁned as G(t) ¼ ÆdI(t)dI(t 1 t)æ/ÆI(t)æ2. For identical
ﬂuorescent particles undergoing Brownian motion in a three-
dimensional Gaussian focus volume element, the autocorre-
lation curve can be described with the equation (Hess et al.,
2002)
GðtÞ ¼ 1
N
3 gðtÞ
¼ 1
N
11
T
1 T e
t=tTr
 
1
11 t=tD
 
3
1
11 t=S2tD
 1
2
; (1)
where N is the average number of the ﬂuorescent molecules
in the laser focus and tD is the correlation time of the
particles. The correlation time represents the diffusion time,
or the average passage time of the molecule through the
focus volume, and is deﬁned by the Einstein equation tD ¼
v2/4D, where v2 is the square of the radius of the laser focus
and D is the diffusion constant. The structural parameter S,
the ratio of the distances from the center of the laser beam
focus in the radial and axial directions, respectively, was
determined from measurements with Rhodamine 6G to be
S ¼ 5.2 and the focus volume was 0.13 ﬂ. The fraction of
ﬂuorophores in the triplet state T and the triplet lifetime tTr
are ﬁtting parameters for the triplet characteristics in
autocorrelation curves. For Alexa488, they were determined
by ﬁt of the data in Fig. 2 A.
In the case of a multicomponent system, the measured
correlation function G(t) is a weighted sum of the
autocorrelation functions of each component Gi(t) (i ¼ 1,
2, . . .M) (Clamme et al., 2003; Thompson, 1991) as
GðtÞ ¼ +
M
i¼1
q2i N
2
i GiðtÞ
.
+
M
i¼1
qiNi
 2
¼ +
M
i¼1
Ai giðtÞ; (2)
where Ni is the mean particle number and qi is the ratio of the
ﬂuorescence yield of the ith component (given by the product
of the detection efﬁciency, absorption cross section, and
ﬂuorescence quantum yield) to that of the ﬁrst component.
We consider only two diffusing species: the ﬂuorescently
labeled peptides (index P) and LUVs with bound ﬂuores-
cently labeled peptides (index V). We used Eq. 2 for the data
analysis with the amplitudes given by
AP ¼ NPðNP1aNVÞ2
and AV ¼ ðaNVÞ
2
N#ðNP1aNVÞ2
; (3)
where NP and NV denote the number of free peptides and
vesicles, respectively. N# is the number of slowly diffusing
particles that can be detected (i.e., vesicles with $1 bound
ﬂuorescent peptide). The value a is the ratio of the
ﬂuorescence yield of vesicles with peptides bound to that
of free peptide and represents the average number of peptides
bound per vesicle if the binding does not change the
ﬂuorescence quantum yield and the detection efﬁciency.
(Indeed, the binding of our peptide to vesicles does not
change the ﬂuorescence intensity of the Alexa-488 ﬂuo-
rophore, as measured with a conventional spectrometer (data
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not shown), provided the number of bound peptides is
sufﬁciently low that self-quenching does not occur.) When
the average number of peptides bound per vesicle, a, is #1,
the number of particles that can be detected with the slow
diffusion time (i.e., vesicles) is equal to the number of
vesicle-bound peptides: N# ¼ aNv. For most of our
measurements (e.g., low lipid concentration, molar partition
coefﬁcient K . 104 M1), the average number of peptides
bound per vesicle, a, is $ 1; in this case, the number of
particles with the slow (vesicle) diffusion is equal to the total
number of vesicles present: N# ¼ Nv.
Under our experimental conditions, we were not able to
determine a accurately with these types of measurements.
Our calculation of a from the amplitudes AP and AV yielded
values that are much smaller than expected. A reason for this
discrepancy might be the signal/noise ratio that makes the
determination of AV difﬁcult when many peptides are bound
to a small number of vesicles (,0.1 nM vesicle concentra-
tion; squares and inverted triangles in Fig. 3 D). Quenching
effects could also play a role in determining Av accurately if
a large number of peptides are bound per vesicle (Clamme
et al., 2003), but this effect should not be important under our
experimental conditions. Thus, to calculate the fraction of
peptide bound and deduce the molar partition coefﬁcient, we
only use the behavior of the free peptide as discussed below.
Kinetic considerations
In using Eq. 2, we assume that a bound ﬂuorescent peptide
dissociates only rarely during its diffusion through the
illuminated focus volume. FCS detects two components: the
rapidly diffusing peptide free in solution and the slowly
diffusing peptide bound to vesicles (Elson, 2001). The
conditions we used for the FCS measurements permit us to
ignore kinetic effects based on data from stopped-ﬂow
kinetics experiments (Arbuzova et al., 1997). Speciﬁcally,
the diffusion time of the vesicle/peptide complex (;1700
ms) is shorter than the binding lifetime of the peptide to the
vesicle (approximately the reciprocal of the off constant). For
example, the measured dissociation rate constant for 15:1
PC/PS vesicles is 100 s1, and the corresponding lifetime of
the peptide-vesicle complex (10 ms) is longer than the time
for the vesicle-bound peptide to diffuse across the beam
waist of the laser focus (;2 ms). The lifetime of the peptide-
vesicle complex is .10 ms for vesicles containing .6% PS
because binding of the MARCKS(151–175) to PC/PS
vesicles is a diffusion-limited process (Arbuzova et al.,
1998). Thus the lifetime of the peptide-vesicle complex is
directly proportional to the molar partition coefﬁcient, which
increases with the mole fraction of PS in the vesicle. Even for
a diffusion-limited forward rate constant, the experimental
results we report for vesicles containing 6% PS in Fig. 4
(K ¼ 103 M1) agree well with independent equilibrium
measurements, as expected from the above kinetic analysis.
Thus FCS measurements should be useful for monitoring
protein or peptide binding to 100 nm LUVs if K$ 103 M1.
When proteins or peptides bind only weakly to vesicles,
however, kinetics may affect FCS measurements; e.g., the
molar partition coefﬁcient of MARCKS(151–175) for PC
vesicles is ;100 M1, so the lifetime of the peptide-vesicle
complex is only ;100 ms. This weak binding cannot be
described with Eq. 2. (The kinetics of peptide binding to PC/
PIP2 vesicles becomes complicated when the vesicles
contain ,1% PIP2: the forward rate constant is no longer
diffusion-limited because three PIP2 must diffuse together to
form the appropriate binding site; Wang et al., 2002.)
Determination of the binding constant
The binding of peptides to lipid bilayers can be described by
deﬁning a molar partition coefﬁcient or binding constant, K,
as discussed elsewhere (Ben-Tal et al., 1997; Murray et al.,
1998; Peitzsch and McLaughlin, 1993). K is the proportion-
ality constant between the fraction of peptide bound to the
membrane and the molar concentration of the peptide in the
bulk aqueous phase, [P]. Our measurements used conditions
where the molar concentration of accessible lipid [L]acc is
much greater than the molar concentration of peptides bound
to the membrane [P]mem. If [L]acc [P]mem, the relationship
can be written as [P]mem ¼ K[P][L]. The total molar
concentration of peptide is the sum of the bound and free
peptide concentrations: [P]tot ¼ [P]mem 1 [P]. Combining
these two expressions we obtain
½Pmem
½Ptot
¼ K½Lacc
11K½Lacc
: (4)
[L]acc is ;50% of the total lipid concentration because the
peptide is added to a solution of LUVs and binds only to
the outer leaﬂet of the membrane. We demonstrated that
the peptide cannot penetrate the vesicles in experiments on
giant unilamellar vesicles using a conventional epiﬂuores-
cence microscopy (Gambhir et al., 2004). The molar partition
coefﬁcient deduced from Eq. 4 is the reciprocal of the lipid
concentration that binds 50% of the peptide.
The FCS data provide the amplitudes AP and AV of the two
component correlation function using Eq. 3. Furthermore,
the conservation of mass requires that the total number of
peptides
N0 ¼ aNV1NP (5)
is constant. Using Eqs. 3 and 5, we ﬁnd AP ¼ NP/(NO)2. The
fraction of peptide bound to vesicles is the number density
of bound peptides with respect to the total number of pep-
tides or
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½Pmem
½Ptotal
¼ aNV
N0
¼ N0  APN
2
0
N0
¼ 1 APN0: (6)
Thus, the fraction of peptide bound illustrated in Fig. 4 A is
determined from the amplitude of the free peptide, AP, and
the total number of peptides, N0. AP is calculated from the
two-component autocorrelation function ﬁt of Eq. 2 to data
of the type illustrated in Fig. 3 D. N0 is calculated from the
one-component autocorrelation function ﬁt of Eq. 1 to data
obtained when only peptide is present (e.g., Fig. 2 A or 3 D).
The fraction of peptide bound is plotted versus accessible
lipid concentration (Fig. 4 A) and the binding constant, K, is
determined from ﬁtting these data with Eq. 4. Error bars for
the fraction of peptide bound shown in Fig. 4 A are
calculated using the standard Gaussian formula for error
propagation applied to Eq. 6. For low values of fraction
peptide bound, the error is dominated by the standard
deviation of N0, and for high values, the error is dominated
by the standard deviation of AP. The standard deviations are
not shown in Fig. 4 because they are approximately the same
size as the symbols.
RESULTS
Fig. 2 A shows autocorrelation curves of Alexa-labeled
MARCKS(151–175) and NBD-labeled PC/PS LUVs; the
data were obtained from separate experiments where only
one component was present in solution. We ﬁt the
autocorrelation data using Eq. 1 (the one-component model)
to deduce diffusion times of Alexa-labeled MARCKS(151–
175) and PC/PS vesicles of 66 ms and 1700 ms, respectively.
The corresponding hydrodynamic radii of the peptide and the
vesicle are 2.2 nm and 55 nm, respectively. These values
agree well with the theoretical predictions. The extruded
vesicles exhibited an ideal autocorrelation function, in-
dicating they are monodisperse.
Determining the binding constant K requires accurate
measurement of relative molar concentrations, so we
investigated the effects of signal/noise ratio and concentra-
tion on the FCS measurements. We used dilution experi-
ments, measuring the number of particles in the effective
focus volume as a function of the sample concentration for
PC/PS vesicles (Fig. 2 B) and Alexa-labeled MARCKS(151–
175) (Fig. 2 C). Data points were ﬁt with the function N ¼
c Veff(1 1 n/c)
2 NA, where N denotes the measured particle
number, c the particle concentration, Veff the effective
detection volume, n the relative background, and NA the
Avogadro constant (Langowski et al., 2000). These experi-
ments indicate FCS measurements are suitable in the linear
concentration ranges of 106 M–103 M accessible lipid
(corresponding to 1011 M–108 M vesicle concentration
for 100 nm diameter LUVs) and 109 M–106 M peptide
concentration. The ﬂuctuation of the ﬂuorescence signal
becomes comparable to the background at lower concen-
trations.
Fig. 3 shows binding experiments using 2 nM Alexa-
labeled MARCKS(151–175) with unlabeled 5:1 PC/PS
vesicles. Fig. 3, A–C, show a typical ﬂuorescence signal
versus time records plotted for different lipid concentrations.
(The count rate is the number of photons detected by the
photodiode per time interval and corresponds to the
ﬂuorescence intensity of all ﬂuorescent particles diffusing
simultaneously through the laser focus volume. The software
provides the count rate as an online record during data
FIGURE 2 (A) Autocorrelation curves of Alexa-labeled MARCKS(151–
175) and NBD-labeled PC/PS vesicles (5:1), which have a diameter of 100
nm. The diffusion time, which correlates with the particle size, is ;70 ms
and 1700 ms for peptides and vesicles, respectively. (B and C) Measurement
range and detection limit. The number of particles in the effective volume is
plotted versus the concentration of vesicles (B) and peptides (C) in the
sample. Error bars (mean6 SD) are not shown for data points when they are
smaller than the size of symbols.
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acquisition, giving qualitative information about the peptide
binding to the vesicles.) These records show that the system
is behaving as expected. To resolve single vesicles with
bound peptides, we chose a binning time of;6 ms, which is
comparable to the average diffusion time of a vesicle through
the detection volume. Fig. 3 A shows the record of 2 nM
Alexa-labeled MARCKS with a count rate of ;5–10 kHz;
at this low peptide concentration the average number of
particles in the focus volume (0.13 ﬂ) is only ;0.38 and
single peptides cannot be resolved. When vesicles are added
to the peptide solution, we observe peaks with different
amplitudes (Fig. 3 B): the slower random walk of the
peptide-vesicle complex through the laser focus volume and
the number of peptides bound per vesicle produce higher
peaks. Increasing the vesicle concentration increases the
number of peaks signiﬁcantly (Fig. 3 C), but decreases the
average height of the peaks because the bound peptides are
distributed over a larger number of vesicles. These results are
similar to those obtained in FCS measurements of the com-
plexation of DNA with ﬂuorescently labeled polycations
(Clamme et al., 2003) or a mixture of ﬂuorescein and
ﬂuorescein-coated beads containing many ﬂuorophores (Van
Craenenbroeck and Engelborghs, 2000).
Fig. 3 D shows autocorrelation curves for experiments
where 0%, 15%, 57%, 74%, or 90% (bottom to top) of the
peptide was bound. The lower autocorrelation curve (solid
FIGURE 3 FCS measurements of MARCKS(151–175) binding to PC/PS
LUVs. (A–C) Time-resolved count rates from solutions containing Alexa-
labeled MARCKS(151–175) and 5:1 PC/PS vesicles. (A) The solution
contains 2 nM peptide and no vesicles. (B) The solution contains 2 nM
peptide and 23 107 M lipid. Peaks with different amplitudes appear in the
plot because;15% of the peptide has bound to the vesicles. Peaks represent
the diffusion of a single LUV with ;10 bound peptides through the
illuminated volume. (C) The solution contains 2 nM peptide and 106 M
lipid. The number of peaks increases signiﬁcantly because 57% of the
peptides are now bound to LUVs. (D) The effect of vesicle (lipid)
concentration on the autocorrelation curves obtained from a solution
containing 2 nM peptide. Autocorrelation curves (bottom to top) are shown
for 0 M, 23 107 M, 13 106 M, 23 106 M, and 43 106 M accessible
lipid concentrations, corresponding to 0%, 15%, 57%, 74%, and 90%
peptide bound, respectively. The lines through the data represent the best ﬁt
of the two-component model, Eq. 2.
FIGURE 4 FCS measurements of peptide binding to PC/PS vesicles. (A)
The percentage of peptide bound, deduced from data similar to those
illustrated in Fig. 3 D for 5:1 PC/PS vesicles, is plotted versus the accessible
lipid concentration. The solutions contained 100 mM KCl, 10 mM HEPES,
pH 7, 2 nM Alexa-labeled MARCKS(151–175) and PC/PS vesicles
comprised of 4.8 (s), 9.1 (=), 12.5 (3), 16.7 (h), and 25 (1) mol % PS.
The curves are the least-square ﬁts of Eq. 4 to the data. (B) The molar
partition coefﬁcient, K, is plotted as a function of mol % PS for 2 nM (s)
and 10 nM (n) peptide concentrations. The error bars are not shown in the
graph because they are smaller than the size of the symbols. The straight line
is the least-squares best ﬁt to the data obtained with 2 nM peptide. The FCS
data agree well with centrifugation binding measurements conducted with
2 nM radioactively labeled NEM-MARCKS(151–175) (n), reported by
Arbuzova et al. (2000).
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diamonds) represents the single particle population obtained
when all of the peptides are free. Data were ﬁt by Eq. 1 with
a predetermined structural parameter of S ¼ 5.2, yielding
a diffusion time tD of 66 ms for the free peptide. When the
peptide binds to the vesicles, the autocorrelation curves
exhibit two characteristic diffusion times. The data shown in
Fig. 3 D were ﬁt according to Eq. 2, keeping the diffusion
time of the free peptide ﬁxed at the predetermined value. The
amplitudes AP and AV can be calculated with the two-
component model of Eq. 2. The population of bound
peptides grows as the lipid concentration increases, and
becomes more and more dominant in the autocorrelation
curve. The amplitude G(0) increases simultaneously, in-
dicating that the total number of ﬂuorescent particles in the
focus volume has decreased. This can be explained by the
fact that several peptides bind to each vesicle.
Fig. 4 A shows the binding of MARCKS(151–175) to
PC/PS vesicles with different ratios of PS, plotting the
percentage of peptide bound as a function of the accessible
lipid concentration. The curves are the least-square ﬁts of Eq.
4 to the data. The peptide binds strongly to vesicles with
a high fraction of PS and weakly to those with a low fraction
of PS. Fig. 4 B shows the molar partition coefﬁcients as
a function of mol % PS in the vesicles, deduced from the data
in Fig. 4 A. We repeated some binding measurements using
10 nM peptide as a control; the values obtained (triangles)
agree well with those from experiments using 2 nM peptide
(circles). These data argue strongly that 1), the peptide is
adsorbing as a monomer and 2), the binding of the peptide
does not change signiﬁcantly the surface charge density of
the vesicles. The molar partition coefﬁcient, K, increases
exponentially with the mole fraction of PS in the vesicles,
a result that agrees qualitatively with theoretical calculations
based on the Poisson-Boltzmann equation and the assump-
tion that the monovalent acidic lipids do not redistribute
(Arbuzova et al., 2000).
One key objective of this report is to compare FCS
measurements of peptide binding to vesicles with those
obtained using other well-established techniques. The solid
squares in Fig. 4 B show measurements of the binding of
radioactively labeled MARCKS(151–175) to PC/PS LUVS
using a centrifugation technique (Arbuzova et al., 2000): the
data agree well, indicating that FCS can be used to measure
the binding of peptides and proteins to phospholipid vesicles.
Fig. 5 A illustrates FCS measurements of the binding of
Alexa-labeled MARCKS (151–175) to vesicles containing
the multivalent acidic lipid PIP2 rather than PS (net charge
1). These experiments used 2 nM peptide and PC/PIP2
vesicles containing either 0.5 (triangles) or 1.0 (squares) mol
% PIP2. The percentage of peptide bound is plotted versus
the accessible lipid concentration; the curves indicating the
molar partition coefﬁcients are the least-square ﬁts of Eq. 4.
Fig. 5 B shows the molar partition coefﬁcient determined
from FCS measurements plotted as a function of mol % PIP2
when the peptide concentration was 2 nM (open circles) or
10 nM (open triangles). We have included the molar
partition coefﬁcients determined from centrifugation meas-
urements with 2 nM radioactively labeled MARCKS(151–
175) (solid symbols) for comparison with the FCS data. The
FCS measurements with 2 nM peptide (open circles) agree
qualitatively with these independent centrifugation measure-
ments (solid symbols). When the peptide was present at
a concentration of 10 nM, we observed weaker binding with
the FCS technique (open triangles), in agreement with
centrifugation measurements (not shown). The molar
partition coefﬁcient decreases at higher peptide concen-
trations because when a signiﬁcant number of peptides bind
to the vesicle the concentration of free PIP2 is lower. Pre-
vious work has shown that ;3 PIP2 molecules diffuse to-
gether to form a binding site for the peptide (Rauch et al.,
2002; Wang et al., 2002). The molar partition coefﬁcient of
MARCKS(151–175) and many other basic peptides for
FIGURE 5 FCS measurements of MARCKS(151–175) binding to PC/
PIP2 LUVs. (A) Binding of 2 nM Alexa-labeled MARCKS(151–175) to PC/
PIP2 vesicles comprising 0.5 (n) and 1 (h) mol % PIP2; binding was
determined from FCS data (not shown) similar to those illustrated in Fig. 3
D. The curves are the least-square ﬁts of Eq. 4 to the data. (B) The molar
partition coefﬁcient plotted versus the mol % PIP2 for 2 nM (s, deduced
from the data in A) and 10 nM (n) peptide concentrations. The error bars are
not shown because they are smaller than the size of the symbols. For
comparison, we have included the molar partition coefﬁcients measured
with 2 nM radioactively labeled MARCKS(151–175) using a centrifugation
technique (:, Arbuzova et al., 2000; n, Wang et al., 2001); the agreement
between the FCS and centrifugation data is satisfactory.
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LUVs containing 1% PIP2 is approximately the same as for
15% PS (Wang et al., 2002). In both cases, the binding is due
to nonspeciﬁc electrostatic interactions and will be affected
by the free concentration of charged lipid on the vesicles.
Fig. 5 B shows that if the peptide binds strongly to the
charged lipid, the true value of the partition coefﬁcient can be
determined only in the presence of very low peptide con-
centrations (;nM in this case). These measurements are
difﬁcult (e.g., with radioactive labels) or impossible (e.g.,
with spin labels, most ﬂuorescent labels, ITC, and NMR) to
make using most conventional techniques. The FCS ap-
proach, however, is ideally suited to measure binding in the
range of 1–10 nM.
DISCUSSION
We used FCS to measure the binding of MARCKS(151–
175) to PC/PS vesicles and compared our results to those
obtained with other conventional techniques (Fig. 4 B). We
chose the basic effector domain peptide of MARCKS
because 1), its binding to PC/PS vesicles has been measured
by centrifugation, ﬂuorescence, electrophoretic mobility, and
EPR techniques and 2), the structure of the peptide and its
location in the membrane have been determined. EPR
measurements of spin-labeled peptides, MAS NMR, circular
dichroism, and monolayer penetration experiments show that
the peptide exists at the membrane interface in a nonhelical
extended conformation with its ﬁve Phe groups inserted into
the acyl chain region (Ellena et al., 2003; Qin and Caﬁso,
1996; Victor et al., 1999; Wang et al., 2001; Zhang et al.,
2003). Fig. 4 B shows that FCS measurements of the molar
partition coefﬁcient (open symbols) agree well with the
centrifugation measurements (solid symbols). This demon-
strates the potential of using FCS to study the binding of
more complicated proteins to LUVs. The advantages and
disadvantages of different techniques for measuring peptide-
lipid interactions are described in a recent monograph by
Simon and McIntosh (2002); Berney and Danuser (2003)
review critically the limitations of the ﬂuorescence resonance
energy transfer approach to study interactions.
We conclude by discussing brieﬂy the limitations and
advantages of the FCS technique to monitor the binding of
peptides/proteins to LUVs. One obvious limitation of FCS is
in measuring weak peptide-membrane interactions: if the
lifetime of the peptide on the vesicles is short, i.e., less than the
time for the vesicle to diffuse through the illuminated volume,
FCS is not appropriate. For typical diffusion-limited binding,
this corresponds to K values of ,103 M1 for our peptide.
This is not a serious limitation because other techniques (e.g.,
equilibrium dialysis, centrifugation) can easily be used in this
range. In contrast, we showed that the FCS technique
produces reliable binding measurements for nanomolar
peptide concentrations. It is very difﬁcult, in our experience,
to make experiments in this range using conventional
methods (equilibrium dialysis, centrifugation, ﬁltration)
because both the peptides and lipids typically adsorb onto
the walls of containers, pipettes, etc. Because FCS permits
direct measurement of peptide concentration in solution, any
peptide loss can be monitored during the experiment.
Furthermore, FCS measurements can be carried out rapidly
and require only small quantities of peptide (or protein), an
important consideration when measuring proteins that are
difﬁcult to obtain and/or label. Finally, FCS can measure
a large number of parameters in a small volume element: it can
determine not only concentrations andmobility constants, but
also dynamic and photophysical parameters, as discussed in
several recent reviews (Hess et al., 2002; Krichevsky and
Bonnet, 2002; Schwille and Haustein, 2002; Thompson et al.,
2002).
This work was supported by the Deutsche Forschungsgemeinschaft grant
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